HomeCompareASPCF vs PEP

ASPCF vs PEP: Dividend Comparison 2026

ASPCF yields 909.59% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ASPCF wins by $8291497.62M in total portfolio value
10 years
ASPCF
ASPCF
● Live price
909.59%
Share price
$0.22
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8291497.77M
Annual income
$6,817,159,983,407.13
Full ASPCF calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — ASPCF vs PEP

📍 ASPCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASPCFPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASPCF + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ASPCF pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASPCF
Annual income on $10K today (after 15% tax)
$77,314.90/yr
After 10yr DRIP, annual income (after tax)
$5,794,585,985,896.06/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, ASPCF beats the other by $5,794,585,933,301.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASPCF + PEP for your $10,000?

ASPCF: 50%PEP: 50%
100% PEP50/50100% ASPCF
Portfolio after 10yr
$4145748.95M
Annual income
$3,408,580,022,641.40/yr
Blended yield
82.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

ASPCF
No analyst data
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASPCF buys
0
PEP buys
0
No recent congressional trades found for ASPCF or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASPCFPEP
Forward yield909.59%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$8291497.77M$141.9K
Annual income after 10y$6,817,159,983,407.13$61,875.67
Total dividends collected$8177275.77M$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: ASPCF vs PEP ($10,000, DRIP)

YearASPCF PortfolioASPCF Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$101,659$90,958.70$10,849$509.42+$90.8KASPCF
2$972,957$864,181.69$11,969$750.47+$961.0KASPCF
3$8,770,897$7,729,833.49$13,500$1,124.14+$8.76MASPCF
4$74,508,241$65,123,381.48$15,680$1,721.66+$74.49MASPCF
5$596,751,110$517,027,292.00$18,929$2,715.34+$596.73MASPCF
6$4,508,591,853$3,870,068,165.34$24,023$4,450.80+$4508.57MASPCF
7$32,150,599,702$27,326,406,419.03$32,510$7,669.92+$32150.57MASPCF
8$216,516,638,004$182,115,496,323.36$47,709$14,093.60+$216516.59MASPCF
9$1,377,885,778,910$1,146,212,976,244.92$77,415$28,083.48+$1377885.70MASPCF
10$8,291,497,766,840$6,817,159,983,407.13$141,922$61,875.67+$8291497.62MASPCF

ASPCF vs PEP: Complete Analysis 2026

ASPCFStock

Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; and Noctiva, a vasopressin analog indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void. It also engages in developing Lidbree, a short acting lidocaine formulation delivered through a proprietary device into the vaginal mucosal tissue; Stendra, a PDE5 inhibitor for the treatment of erectile dysfunction; Tefina, a clinical stage product for women with female sexual dysfunction; and Noctiva combination products, which are in the pre-clinical development stage for the treatment of benign prostatic hypertrophy, overactive bladder, and pediatric nocturnal enuresis. In addition, the company provides TriVair technology platform for pulmonary and nasal dosing. It sells its products through its salesforce in the United States and Canada; and through a network of distributors internationally. The company was formerly known as Trimel Pharmaceuticals Corporation and changed its name to Acerus Pharmaceuticals Corporation in September 2015. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada.

Full ASPCF Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this ASPCF vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASPCF vs SCHDASPCF vs JEPIASPCF vs OASPCF vs KOASPCF vs MAINASPCF vs MOASPCF vs PMASPCF vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.